ReviewHeliyon2025
Metal-organic framework catalysed multicomponent reactions towards the synthesis of Pyrans.
Review in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Veterinary Regenerative Medicine: The Evolving Role of Stem Cell-Based Therapies.Stem cell reviews and reports · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal-Organic Frameworks (MOFs) gaining increasing interest in heterogeneous catalysis owing to their advantageous properties such as superior porosity, high surface area, ample catalytic sites. Their properties can be tailored by varying the metal ions or metal clusters (nodes) and organic linkers. Magnetically active nano core-shell MOF composites are also discovered for easy separation and reuse of catalyst. MOF catalysed multicomponent reactions (MCRs) satisfy several green chemistry principles and thus can be considered as a sturdy step towards sustainable chemical synthesis. In this article, synthesis of biologically potent pyran scaffolds through MOF catalysed MCR approaches have been reviewed. Preparation of MOF catalyst, its catalytic performance in pyran synthesis, reusability has been discussed with reaction for each example.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.